BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu ZH, Bao ED. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk. Mol Biol Rep 2013;40:2389-95. [PMID: 23184052 DOI: 10.1007/s11033-012-2319-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 de Maturana EL, Rava M, Anumudu C, Sáez O, Alonso D, Malats N. Bladder Cancer Genetic Susceptibility. A Systematic Review. Bladder Cancer 2018;4:215-26. [PMID: 29732392 DOI: 10.3233/BLC-170159] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
2 Li J, Chen Y, Mo Z, Li L. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations. Eur J Obstet Gynecol Reprod Biol 2015;189:73-8. [PMID: 25889195 DOI: 10.1016/j.ejogrb.2015.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 Zhou X, Zhang G, Tian Y, Seno M. p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette–Guérin: A Meta-Analysis. PLoS ONE 2015;10:e0119476. [DOI: 10.1371/journal.pone.0119476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
4 Wang L, Su G, Zhao X, Cai Y, Cai X, Zhang J, Liu J, Wang T, Wang J. Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk. Tumour Biol 2014;35:1139-42. [PMID: 24014088 DOI: 10.1007/s13277-013-1152-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]